Fennec Pharmaceuticals Inc.
FENC
$6.01
-$0.005-0.08%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -33.94% | -6.35% | -15.88% | 285.74% | 7.02% |
| Total Receivables | -0.19% | 4.84% | 19.84% | 16.56% | 94.78% |
| Inventory | -5.78% | -47.53% | 3.88% | -4.27% | 22.85% |
| Prepaid Expenses | 0.46% | -29.98% | -2.43% | 74.29% | 942.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -14.65% | 92.93% | 75.78% | 265.91% | 120.00% |
| Total Current Assets | -23.88% | -6.77% | -8.80% | 153.82% | 41.76% |
|
|
|||||
| Total Current Assets | -23.88% | -6.77% | -8.80% | 153.82% | 41.76% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -14.02% | -3.34% | -3.23% | 16,933.33% | -88.68% |
| Total Assets | -23.72% | -6.71% | -8.72% | 157.57% | 41.18% |
|
|
|||||
| Total Accounts Payable | -16.19% | -13.04% | -14.55% | 37.74% | 28.46% |
| Total Accrued Expenses | 3.47% | 9.05% | -30.37% | 16.22% | 294.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -71.43% | -41.67% | -29.41% | -19.05% | 0.00% |
| Total Finance Division Other Current Liabilities | 0.00% | -1.59% | 0.00% | -- | -- |
| Total Other Current Liabilities | 0.00% | -1.59% | 0.00% | -- | -- |
| Total Current Liabilities | -6.94% | -4.05% | -21.22% | 30.23% | 93.02% |
|
|
|||||
| Total Current Liabilities | -6.94% | -4.05% | -21.22% | 30.23% | 93.02% |
| Long-Term Debt | -39.75% | 1.01% | 1.36% | 1.35% | 20.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | -1.73% | 0.00% | 1,249,600.00% | -- |
| Total Liabilities | -20.71% | -0.66% | -2.51% | 71.96% | 30.20% |
|
|
|||||
| Common Stock & APIC | 0.61% | 0.92% | 0.57% | 0.87% | 0.78% |
| Retained Earnings | -0.91% | -2.71% | -2.69% | 5.86% | -1.24% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -13.56% | -281.06% | -145.02% | 125.93% | -10.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.56% | -281.06% | -145.02% | 125.93% | -10.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.56% | -281.06% | -145.02% | 125.93% | -10.36% |
|
|
|||||